Sensex 27828.44 321.73 (1.17%)29-May-15 16:00
Nifty 8433.65 114.65 (1.38%)29-May-15 00:00
The much awaited 3-day CPhI/P-MEC/ICSE/ BioPh exhibition for the pharmaceutical industry is all set to open in Mumbai on November 21, 2012. The exhibition will have participation of over 920 companies from all over the world, making it South Asia’s largest pharmaceutical event. Visitor pre-registrations also show very encouraging numbers of attendees from over 90 countries interesting in visiting CPhI/P-MEC/ICSE/ BioPh.
According to the India Business Equity Foundation, the Indian pharmaceutical market is set to double its exports to reach US$500 billion by 2014, thereby attracting the attention of major global economies.
Growing at a pace of 15% annually, it is no secret that Generics are the major strength of the Indian pharmaceutical sector. With a strong domestic market potential and the low-cost manufacturing advantage working in its favour, India is set to become increasingly prominent on the global pharmaceutical landscape in the near future.
Rajeev Kher, Additional Secretary, Department of Commerce, Ministry of Commerce and Industry, will be the Guest of Honour at the inaugural session to be held on November 21, 2012. The platform will provide an opportunity for attendees and exhibitors to interact and network with the industry players from the various segments within the field of pharmaceutical ingredients, machinery, equipment & technology, contract services and solutions. Onsite seminars will address various technology issues and the latest industry trends.
The CPhI India Awards will recognise and appreciate the contribution and efforts of the Indian pharmaceutical industry. There are seven broad categories identified for the awards. The categories include innovation in quality, product development, cost, the environment, Health & Safety (EHS), packaging and the lifetime achievement and Pharma Personality of the Year awards.
The process advisors for the awards are Ernst & Young. Organised by UBM, the CPhI India Awards are supported by Pharmexcil and Brand India Pharma. The evaluation for the awards will be done by an independent panel of senior industry professionals. The award distribution event will be held on 21st November, 2012.
CPhI India Awards 2012 will be an elite gathering of industry leaders who will meet, network and also attend a panel discussion on “Developing the Capability, Credibility and Culture to penetrate deeper into the global value chain for the Indian Pharma Industry”.
India Infoline Research Team / 14:59, May 20, 2015
GPIL reported 13.5% yoy decline in operating profit as the impact of higher volumes was offset by lower product prices